![Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failure]()
Fedratinib in patients with myelofibrosis previously treated with ruxolitinib: An updated analysis of the JAKARTA2 study using stringent criteria for ruxolitinib failureHarrison, Claire N.; Schaap, Nicolaas; Vannucchi, Alessandro M.; Kiladjian, JeanâJacques; Jourdan, Eric; Silver, Richard T.; Schouten, Harry C.; Passamonti, Francesco; Zweegman, Sonja; Talpaz, Moshe; Verstovsek, Srdan; Rose, Shelonitda; Shen, Juan; Berry, Tymara; Brownstein, Carrie; Mesa, Ruben A. · American Journal of Hematology · 2020